medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2024, Number 07

<< Back

Ginecol Obstet Mex 2024; 92 (07)

Relation of polymorphism g-238a of tumor necrosis factor alpha with recurrent pregnancy loss

Gutiérrez CR, Rosas CA, Robles MMC, Reyes MA, García MED, Vázquez RE

Language: Spanish
References: 24
Page: 303-314
PDF size: 254.80 Kb.


ABSTRACT

Objective: To determine if there is an association between polymorphisms G-308A (rs1800629) and G-238A (rs361525) of the tumor necrosis factor alpha (TNF-α) with the presence of recurrent pregnancy loss in patients treated at the Women's Hospital of the City of Aguascalientes.
Materials and Methods: An observational, case-control study was conducted in 150 patients with recurrent pregnancy loss and 150 patients with normal pregnancies. Different clinical variables were studied and the polymorphisms of the TNF-α tumor gene, G-308A (rs1800629) and G-238A (rs361525). Were genotyped by restriction fragment length polymorphism (RFLP) reaction and the prevalences of the genotypes between both groups was compared, as well as the Odds ratios (OR) of the genotypes and mutated alleles using various genetic models. Multivariate analysis was performed to determine the effect of clinical variables and the presence of these polymorphisms.
Results: Patients with recurrent pregnancy loss were significantly older, had more miscarriages and a lower gestational age than those in the control group. For the G-308A (rs1800629) polymorphism, no significant difference was observed in the prevalences between both groups. For G-238A (rs361525) the prevalence was 6.7% for patients and 1.7% for women with normal pregnancies, with a statistically significant difference (p = 0.004). None of the different genetic models showed a significant increase for G-308A (rs1800629), however, for G-238A (rs361525) the heterozygous (OR 4.36, 95%IC: 1.2-15.78; p=0.012) and dominant (OR 4.36, 95%IC: 1.42-13.36, p=0.005) models did show an increase in said probability. In the multivariate analysis, no clinical variable showed statistical significance.
Conclusion: The G-238A (rs361525) polymorphism of the tumor necrosis factor alpha gene shows an association, and a higher risk of recurrent pregnancy loss in our population.


REFERENCES

  1. Bagkou Dimakou DB, Lissauer D, Tamblyn J, CoormarasamyA, et al. Understanding human immunity inidiopathic recurrent pregnancy loss. Eur J Obstet GynecolReprod Biol 2022; 270: 17-29. https://doi.org/10.1016/j.ejogrb.2021.12.024

  2. Practice Committee of the American Society for ReproductiveMedicine. Definitions of infertility and recurrentpregnancy loss: a committee opinion. Fertility andSterility 2020; 113 (3). https://doi.org/10.1016/j.fertnstert.2019.11.025

  3. Hong LY, Marren A. Recurrent pregnancy loss. A summaryof international evidence-based guidelines and practice.Aust J Gen Pract 2018; 47 (7): 432-36. https://doi.org/10.31128/AJGP-01-18-4459

  4. Mateo-Sanez HA, Mateo-Sanez E, Hernández-Arroyo L,Rivera-Ramírez P, et al. Pérdida recurrente del embarazo:revisión bibliográfica. Ginecol Obstet Mex 2016; 84 (8): 523-534. PMID 29424514.

  5. Argilés JM, Carbó N, López-Soriano FJ. TNF and pregnancy:the paradigm of a complex interaction. Cytokine GrowthFactor Rev 1997; 8 (3): 181-88. https://doi.org/10.1016/s1359-6101(97)00012-9

  6. Dai FF, Hu M, Zhang YW, Zhu RH, et al. TNF-α/anti-TNF-α drugs and its effect on pregnancy outcomes. ExpertRev Mol Med 2022; 24: e26. https://doi.org/10.1017/erm.2022.18

  7. Fragoso JM, Vargas Alarcón G, Jiménez Morales S, ReyesHernández OD, et al. El factor de necrosis tumoral α (TNF-α)en las enfermedades autoinmunes (EA): biología moleculary genética. Gac Med Mex 2014; 150: 334-44.

  8. Hui HL, Xing HX, Jing T, Kai-Yue Z, et al. Association ofTNF-α genetic polymorphisms with recurrent pregnancyloss risk: a systematic review and meta-analysis. ReprodBiol Endocrinol 2016; 14: 6. https://doi.org/10.1186/S12958-016-0140-6

  9. Quintero-Ramos A, Valdez-Velázquez LL, Hernández G,et al. Assessment of five thrombophilic genetic polimorphismsamong couples with habitual abortion. Gac MedMex 2006; 142 (2): 95-8.

  10. Alonso-Barragán SA, Gutiérrez-Amavizca BE, Salazar-Dávalos IM, Aceves-Aceves MA, et al. Polimorfismos -308g>A y -238 G>A del gen TNF-α en aborto recurrente. RevMed Cos Rica y Cent 2014; LXXI (611): 431-436.

  11. Sudhir N, Badaruddoza Beri A, Kaur A. Association of tumornecrosis factor‑alpha 308G/A polymorphism with recurrentmiscarriages in women. J Hum Reprod Sci 2016; 9 (2): 86-9.https://doi.org/10.4103/0974-1208.183516

  12. Stavros S, Mavrogianni D, Papamentzelopoulou M, BasamakisE, et al. Association of tumor necrosis factor-α-308G>A, -238G>A and -376G>A polymorphisms withrecurrent pregnancy loss risk in the Greek population.Fertil Res Pract 2021; 10: 7 (1): 9. https://doi.org/10.1186/S40738-021-00101-X

  13. Jianting Ma, Xingguang Zhang X, Gang He, Chunlin Yang.Association between TNF, IL1B, IL6, IL10 and IFNG polymorphismsand recurrent miscarriage: a case controlstudy. Reprod Biol Endocrinol 2017; 15 (1): 83. https://doi.org/10.1186/S12958-017-0300-3

  14. Palmirotta R, La Farina F, Ferroni P, et al. Polimorfismospromotores del gen TNFA y susceptibilidada la pérdida recurrente del embarazo en mujeresitalianas. Reprod Sci 2010; 17 (7): 659-66. https://doi.org/10.1177/1933719110366603.

  15. Daher S, Shulzhenko N, Morgun A, et al. Asociaciones entrelos polimorfismos del gen de las citoquinas y la pérdidarecurrente del embarazo. J Reprod Immunol 2003; 58 (1):69-77. https://doi.org/10.1016/S0165-0378(02)00059-1

  16. Wysocka U, Sakowicz A, Jakubowski L, et al. Associationbetween idiopathic recurrent pregnancy loss and geneticpolymorphisms in cytokine and matrix metalloproteinasegenes. Ginekol Pol 2021; 92 (6): 440-45. https://doi.org/10.5603/GP. a2021.0089

  17. Aboutorabi R, Behzadi E, Javad Sadegh M, et al. The Studyof Association Between Polymorphism of TNF-α Gene’sPromoter Region and Recurrent Pregnancy Loss. J ReprodInfertil 2018; 19 (4): 211-18. PMID:30746336

  18. Zammiti W, Mtiraoui N, Finan RR, et al. Tumor necrosis factorand lymphotoxin a haplotypes in idiopathic recurrentpregnancy loss. Fertility and Steility 2009; 91 (5): 1903-8.https://doi.org/10.1016/j.fertnstert.2008.01.090.

  19. Dong J, Li J, Zhou G, et al. No association between TNF-α-308G/A polymorphism and idiopathic recurrent miscarriage:a systematic review with meta-analysis and trialsequential analysis. PLoS One 2016; 11 (11): e0166892.https://doi.org/10.1371/journal.pone.0166892

  20. Li HH, Xu XH, Tong J, et al. Association of TNF-α geneticpolymorphisms with recurrent pregnancy lossrisk: a systematic review and meta-analysis. ReprodBiol Endocrinol 2016; 14: 6. https://doi.org/10.1186/s12958-016-0140-6.

  21. Kim JA, Bang CH, Song GG, et al. Tumor necrosis factoralpha gene polymorphisms in women with recurrentpregnancy loss: a meta-analysis. Human Fertility 2020;23 (3): 159-169. https://doi.org/10.1080/14647273.2018.1543899.

  22. Liu RX, Wang Y, Wen LH. Relationship between cytokinegene polymorphisms and recurrent spontaneous abortion.Int J Clin Exp Med 2015; 8 (6): 9786-92. PMID: 26309657

  23. Hantoushzadeh S, Kohandel Gargari O, Shafiee A, et al.Glucose metabolism tests and recurrent pregnancy loss:evidence from a systematic review and meta-analysis. DiabetolMetabol Syndr 2023; 15: 3. https://doi.org/10.1186/s13098-022-00973-z

  24. Ticconi C, Nicastri E, D´Ippolito S, et al. Diagnostic factorsfor recurrent pregnancy loss: an expanded workup.Arch Gynecol Obstet 2023; 308 (1): 127-42. https://doi.org/10.1007/S00404-023-07001-Z




2020     |     www.medigraphic.com